Citadel Advisors
MORF

Citadel Advisors’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Citadel Advisors’s Portfolio MORF Stock Details MORF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-28,800
Closed -$981K – 15608
2024
Q2 		$981K Buy
28,800
+7,500
+35% +$222K ﹤0.01% 6613
2024
Q1 		$750K Buy
21,300
+17,700
+492% +$593K ﹤0.01% 7523
2023
Q4 		$104K Sell
3,600
-5,100
-59% -$121K ﹤0.01% 10883
2023
Q3 		$199K Sell
8,700
-300
-3% -$15.7K ﹤0.01% 9916
2023
Q2 		$516K Buy
9,000
+7,700
+592% +$402K ﹤0.01% 7868
2023
Q1 		$48.9K Buy
1,300
+1,100
+550% +$40.5K ﹤0.01% 12178
2022
Q4 		$5.35K Buy
+200
New +$5.47K ﹤0.01% 14009

Other funds holding MORF

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
HI
Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return

Citadel Advisors's MORF Position: Q3 2024 in Review

Citadel Advisors sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 161,988 shares — an estimated $5.52M sold.

Citadel Advisors first reported a position in MORF in Q2 2019 and held it in 16 quarters. The position peaked at $30.5M in Q1 2024. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

  • Citadel Advisors reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 161,988 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $5.52M.
  • Citadel Advisors first reported a position in Morphic Holding, Inc. Common Stock in Q2 2019 and held it in 16 quarters.
  • Citadel Advisors's Morphic Holding, Inc. Common Stock position peaked at $30.5M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.